In our study of colon cancer, we found that, in contrast to pim-1-negative immune inflammatory cells, pim-1-positive immune inflammatory cells that accompany cancer-associated fibroblasts were associated with increased DFS and OS, perhaps acting as tumor-killing subclasses of immune cells. This evidence concerns the gene PIM1 and colonic neoplasm.